Front Cover; Advances in Immunology, Volume 37; Copyright Page; Contents; Contributors; Chapter 1. Structure, Function, and Genetics of Human Class II Molecules; I. Introduction; II. HLA-DR Serology/HTC; III. HLA-DQ Serology; IV. HLA-DP Serology/HTC; V. Deletion Mutants; VI. Monoclonal Antibodies to HLA-D Region Products; VII. HLA-DR Biochemistry; VIII. HLA-DQ Biochemistry; IX. HLA-DP Biochemistry; X. Supertypic Specificity Localization; XI. Invariant (Gamma) Chain; XII. Genes; XIII. Restriction Fragment Length Polymorphism; XIV. Function; XV. Conclusion; References.

Chapter 2. The Complexity of Virus-Cell Interactions in Abelson Virus Infection of Lymphoid and Other Hemotopoietic CellsI. Introduction; II. Neoplastic Transformation by A-MuLV; III. Nonneoplastic Changes Induced by v-abl; IV. The Complexity of Abelson Disease; V. The Complexity of A-MuLV Transformation in Vitro; References; Chapter 3. Epstein-Barr Virus Infection and lmmunoregulation in Man; I. Introduction; II. Polyclonal B Cell Activation by EBV; III. Relationship between EBV-Induced Immunoglobulin Production and Immortalization; IV. Infectious Mononucleosis.

V. Immunoregulatory Cell Functions in Acute Infectious MononucleosisVI. Persistent EBV Infection in Normal Individuals; VII. Selected Disorders Associated with an Abnormal Regulation of EVB Infection; VIII. Reversal of Infectious Mononucleosis-Associated Suppressor T Cell Activity By D-Mannose: Supression and Saccharides; IX. Concluding Remarks; References; Chapter 4. The Classical Complement Pathway: Activation and Regulation of the First Complement Component; I. Introduction; II. History of the Classical Pathway of the Complemnt System; III. The Proteins of the C1 Activation Unit.

IV. The Complexes of the C1 Activation UnitV. The C1 Activation Process; VI. Actions of Activated C1; VII. Regulations and Fate of Activated C1; VIII. Comment; References; Chapter 5. Membrane Complement Receptors Specific for Bound Fragments of C3; I. Background; II. Generation of the Ligands for C3 Receptors; III. Structure and Binding Site Characteristics of the Receptors; IV. Functions of C3 Receptors; V. Conclusions; References; Chapter 6. Murine Models of Systemic Lupus Erythematosus; I. Introduction; II. Derivation of Lupus Mice; III. Natural History and Pathology of Lupus Mice.

IV. Cellular AbnormalitiesV. Genetics of Murine SLE; VI. Influence of Sex and Sex Hormones on the Pathogenesis of Murine SLE; VII. Viruses in Murine SLE; VIII. Treatment of Murine SLE; IX. Conclusions; References; Index; Contents of Recent Volumes.